Results 11 to 20 of about 386,601 (205)

The Influence of Quality of Measles Vaccine to The Incidence of Measles in Pasuruan Regency

open access: yesJurnal Berkala Epidemiologi, 2015
The measles is a major cause of child mortality among vaccine preventable disease. The incidence of measles reach out 198 cases in 2014 at Pasuruan. The incidence of measles in Pasuruan, not only in areas with low immunization coverage but also in areas ...
Dwi Wahyu Ningtyas, Arief Wibowo
doaj   +3 more sources

Effectiveness of interventions to improve the uptake of immunisation in primary care, with specific focus on Mumps, Measles and Rubella (MMR) [PDF]

open access: yes, 2009
Background: There has been a decade of MMR vaccine uptake which is below the threshold for herd immunity for measles and large numbers of children are unprotected. The number of measles cases in England is now rising (DH, 2008).
Morrell, Jane   +3 more
core   +4 more sources

Following in the footsteps of smallpox: can we achieve the global eradication of measles? [PDF]

open access: yes, 2004
BACKGROUND: Although an effective measles vaccine has been available for almost 40 years, in 2000 there were about 30 million measles infections worldwide and 777,000 measles-related deaths.
Morgan Oliver WC   +2 more
core   +2 more sources

Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants. [PDF]

open access: yes, 2010
BACKGROUND: Epstein-Barr virus (EBV) and cytomegalovirus (CMV) are persistent herpesviruses that have various immunomodulatory effects on their hosts. Both viruses are usually acquired in infancy in Sub-Saharan Africa, a region where childhood vaccines ...
Ebrima S Touray   +83 more
core   +1 more source

Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models [PDF]

open access: yes, 2009
We evaluated the effectiveness of a measles vaccine campaign in rural Kenya, based on oral-fluid surveys and mixture-modelling analysis. Specimens were collected from 886 children aged 9 months to 14 years pre-campaign and from a comparison sample of 598
Brown, D. W. G.   +9 more
core   +1 more source

Measles immunity gap among reproductive-age women participating in a simulated HIV vaccine efficacy trial in Zambia

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Measles is a vaccine-preventable viral disease whose vaccination coverage remains low in Zambia, where the target group for vaccination is children aged 9 to 18 months.
Kalonde Malama   +11 more
doaj   +1 more source

Measles elimination: progress, challenges and implications for rubella control. [PDF]

open access: yes, 2013
Measles and rubella are major vaccine-preventable causes of child mortality and disability. They have been eliminated from the Americas and some other regions have also come close to elimination.
Lessler, Justin   +7 more
core   +1 more source

Measles Vaccine [PDF]

open access: yesViral Immunology, 2018
Measles remains an important cause of child morbidity and mortality worldwide despite the availability of a safe and efficacious vaccine. The current measles virus (MeV) vaccine was developed empirically by attenuation of wild-type (WT) MeV by in vitro passage in human and chicken cells and licensed in 1963.
openaire   +2 more sources

Estimation of the basic reproduction number of measles during an outbreak in a partially vaccinated population [PDF]

open access: yes, 2000
From March to July 1996 a measles outbreak occurred in northern Luxembourg with 110 reported cases centered around two primary schools (85 cases) and the surrounding community (25 cases). Eighty four suspected cases were confirmed serologically.
Muller, C. P.   +3 more
core   +1 more source

EXPERIMENTAL MEASLES VACCINES: A RESEARCH TOOL IN VACCINATION EVENTS

open access: yesМедицинская иммунология, 2014
. The review article considers different variants of measles vaccine that may be classified into two groups, i.e., vaccines that do not contain viable measles virus, and attenuated measles vaccines which could be employed in unusual manner.The first ...
V. A. Liashenko
doaj   +1 more source

Home - About - Disclaimer - Privacy